Skip to main content
    E

    Edesa Biotech Inc (EDSA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.96
    +0.07 (+3.70%)

    Market Cap: $25.54M

    Last updated: Nov 17, 2026 at 4:26 PM ET

    Edesa Biotech Inc (EDSA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Edesa Biotech (EDSA) has a market cap of $25.54M and an enterprise value of $15.20M. It kept -27695.45% of revenue as net income over the last 12 months. Its share count is up 28.26% from a year earlier.

    Total Valuation

    Enterprise value is 40.46% below the market cap, as cash exceeds debt.

    Market Cap$25.54M
    Enterprise Value$15.20M
    Latest price (Nov 17, 2026)$1.96

    Key Dates

    The next earnings report is expected on Dec 10, 2026, covering the quarter ending Sep 30, 2026.

    Next Earnings DateDec 10, 2026 (expected)
    Last Earnings DateAug 13, 2026
    Fiscal Year EndSeptember

    Share Statistics

    The share count rose 5.46% in the quarter ended Jun 30, 2026 and grew 67.21% a year over 2 years.

    Shares Outstanding9.01M
    Shares Change (YoY)+28.26%
    Shares Change (QoQ)+5.46%
    Share Count Growth (2Y CAGR)+67.21%

    Valuation Ratios

    P/B Ratio2.0x
    P/TBV Ratio2.6x

    Price Statistics

    The stock is up 12.32% over 52 weeks and trades 38.17% below its 50-day average.

    Beta (1Y)0.00
    52-Week Change+12.32%
    1-Month Change-29.50%
    3-Month Change-65.91%
    6-Month Change-83.60%
    5-Year Change-95.53%
    10-Year Change-99.58%
    Total Return (1Y)+12.32%
    Total Return (3Y CAGR)-13.32%
    Total Return (5Y CAGR)-46.84%
    Return vs SPY (1Y)+1.08%
    Max Drawdown (1Y)-89.66%
    Max Drawdown (3Y)-89.66%
    Sharpe Ratio (1Y)0.07
    Correlation with SPY (1Y)0.00
    50-Day Average$3.17
    200-Day Average$5.70
    52-Week Range$0.72 to $20.32
    RSI (14 Days)34.5
    Average Volume (20 Days)4.50M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.76x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.76x
    Quick Ratio2.76x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -160.05% and return on assets is -110.85% over the last 12 months.

    Return on Equity (ROE)-160.05%
    Return on Assets (ROA)-110.85%
    Asset Turnover0.00x
    Receivables Turnover0.00x

    Scores

    EDSA has an Altman Z-Score of -8.95, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-8.95
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $50.92K over the last 12 months.

    Revenue$50.92K
    Gross Profit-$102.84K
    Operating Income-$14.63M
    Pretax Income-$14.10M
    Net Income-$14.10M
    Reported EPS (TTM)-$1.69

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 69.26% of the $12.72M in total assets.

    Cash and Equivalents$10.33M
    Total Debt$0
    Net Cash$10.33M
    Net Cash Per Share$1.15
    Working Capital$6.87M
    Shareholder Equity$8.81M
    Book Value Per Share$0.98
    Tangible Book Value$6.91M
    Tangible Book Per Share$0.77
    Total Assets$12.72M
    Total Liabilities$3.91M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $17 of capital spending, operating cash flow left -$8.95M of free cash flow.

    Operating Cash Flow-$8.95M
    Capital Expenditures$17
    Free Cash Flow-$8.95M
    FCF Per Share-$0.66
    Depreciation and Amortization$102.84K

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -28728.89%.

    Gross Margin-201.98%
    Operating Margin-28728.89%
    Pretax Margin-27693.88%
    Net Margin-27695.45%
    FCF Margin-17581.58%

    Growth

    Book Value Per Share Growth (2Y CAGR)-12.93%
    Tangible Book Per Share Growth (2Y CAGR)-3.92%

    Revenue and profit by year

    Dividends and Yields

    EDSA does not pay a dividend. Its free cash flow yield is -50.71%.

    FCF Yield-50.71%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-7 reverse split on Oct 11, 2023.

    Last Split DateOct 11, 2023
    Split TypeReverse split
    Split Ratio1:7

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About EDSA

    What is EDSA's market cap?

    Edesa Biotech has a market cap of $25.54M. Its enterprise value, which adds debt and subtracts cash, is $15.20M.

    How many shares of EDSA are outstanding?

    Edesa Biotech has 9.01M shares outstanding. The count is up 28.26% from a year earlier.

    Does EDSA pay a dividend?

    No. Edesa Biotech does not pay a dividend.

    How much debt does EDSA have?

    Edesa Biotech has $0 of total debt and $10.33M of cash and equivalents, a net cash position of $10.33M.